387 related articles for article (PubMed ID: 19344978)
1. Tumor necrosis factor-alfa in nonhealing venous leg ulcers.
Charles CA; Romanelli P; Martinez ZB; Ma F; Roberts B; Kirsner RS
J Am Acad Dermatol; 2009 Jun; 60(6):951-5. PubMed ID: 19344978
[TBL] [Abstract][Full Text] [Related]
2. The impact of differential expression of extracellular matrix metalloproteinase inducer, matrix metalloproteinase-2, tissue inhibitor of matrix metalloproteinase-2 and PDGF-AA on the chronicity of venous leg ulcers.
Mwaura B; Mahendran B; Hynes N; Defreitas D; Avalos G; Adegbola T; Adham M; Connolly CE; Sultan S
Eur J Vasc Endovasc Surg; 2006 Mar; 31(3):306-10. PubMed ID: 16169261
[TBL] [Abstract][Full Text] [Related]
3. Epithelial tissue-type plasminogen activator expression, unlike that of urokinase, its receptor, and plasminogen activator inhibitor-1, is increased in chronic venous ulcers.
Weckroth M; Vaheri A; Virolainen S; Saarialho-Kere U; Jahkola T; Sirén V
Br J Dermatol; 2004 Dec; 151(6):1189-96. PubMed ID: 15606514
[TBL] [Abstract][Full Text] [Related]
4. S100A8/A9 deficiency in nonhealing venous leg ulcers uncovered by multiplexed antibody microarray profiling.
Trøstrup H; Lundquist R; Christensen LH; Jorgensen LN; Karlsmark T; Haab BB; Agren MS
Br J Dermatol; 2011 Aug; 165(2):292-301. PubMed ID: 21517798
[TBL] [Abstract][Full Text] [Related]
5. Levels of tumor necrosis factor-alpha (TNF-alpha) and soluble TNF receptors in chronic venous leg ulcers--correlations to healing status.
Wallace HJ; Stacey MC
J Invest Dermatol; 1998 Mar; 110(3):292-6. PubMed ID: 9506452
[TBL] [Abstract][Full Text] [Related]
6. Keratinocyte and dermal vascular endothelial cell capacities remain unimpaired in the margin of chronic venous ulcer.
Galkowska H; Olszewski WL; Wojewodzka U
Arch Dermatol Res; 2005 Jan; 296(7):286-95. PubMed ID: 15565301
[TBL] [Abstract][Full Text] [Related]
7. Effect of healing on the expression of transforming growth factor beta(s) and their receptors in chronic venous leg ulcers.
Cowin AJ; Hatzirodos N; Holding CA; Dunaiski V; Harries RH; Rayner TE; Fitridge R; Cooter RD; Schultz GS; Belford DA
J Invest Dermatol; 2001 Nov; 117(5):1282-9. PubMed ID: 11710945
[TBL] [Abstract][Full Text] [Related]
8. Etanercept decreases tumor necrosis factor-alpha activity in chronic wound fluid.
Cowin AJ; Hatzirodos N; Rigden J; Fitridge R; Belford DA
Wound Repair Regen; 2006; 14(4):421-6. PubMed ID: 16939569
[TBL] [Abstract][Full Text] [Related]
9. IL-10 and GM-CSF expression and the presence of antigen-presenting cells in chronic venous ulcers.
Li YQ; Doyle JW; Roth TP; Dunn RM; Lawrence WT
J Surg Res; 1998 Oct; 79(2):128-35. PubMed ID: 9758727
[TBL] [Abstract][Full Text] [Related]
10. Up-regulation of elastase in acute wounds of healthy aged humans and chronic venous leg ulcers are associated with matrix degradation.
Herrick S; Ashcroft G; Ireland G; Horan M; McCollum C; Ferguson M
Lab Invest; 1997 Sep; 77(3):281-8. PubMed ID: 9314951
[TBL] [Abstract][Full Text] [Related]
11. Expression of apoptosis- and cell cycle-related proteins in epidermis of venous leg and diabetic foot ulcers.
Galkowska H; Olszewsk WL; Wojewodzka U; Mijal J; Filipiuk E
Surgery; 2003 Aug; 134(2):213-20. PubMed ID: 12947320
[TBL] [Abstract][Full Text] [Related]
12. Valvular density alone cannot account for sites of chronic venous insufficiency and ulceration in the lower extremity.
Aharinejad S; Nedwed S; Michlits W; Dunn R; Abraham D; Vernadakis A; Marks SC
Microcirculation; 2001 Oct; 8(5):347-54. PubMed ID: 11687946
[TBL] [Abstract][Full Text] [Related]
13. Effect of collagen turnover and matrix metalloproteinase activity on healing of venous leg ulcers.
Meyer FJ; Burnand KG; Abisi S; Tekoppele JM; van Els B; Smith A
Br J Surg; 2008 Mar; 95(3):319-25. PubMed ID: 17854113
[TBL] [Abstract][Full Text] [Related]
14. Increased but ineffectual angiogenic drive in nonhealing venous leg ulcers.
Drinkwater SL; Burnand KG; Ding R; Smith A
J Vasc Surg; 2003 Nov; 38(5):1106-12. PubMed ID: 14603223
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of apoptotic cells and immunohistochemical detection of FAS, FAS-L, Bcl-2, Bax, p53 and c-Myc in the skin of patients with chronic venous leg ulcers.
Heising S; Giebel J; Ostrowitzki AL; Riedel F; Haase H; Sippel K; Jünger M
Int J Mol Med; 2008 Oct; 22(4):497-505. PubMed ID: 18813857
[TBL] [Abstract][Full Text] [Related]
16. Assessment of venous leg ulcers: an in-depth discussion of a literature-guided approach.
Kunimoto BT
Ostomy Wound Manage; 2001 May; 47(5):38-49, 52-3. PubMed ID: 11889721
[TBL] [Abstract][Full Text] [Related]
17. Effect of venous ulcer exudates on angiogenesis in vitro.
Drinkwater SL; Smith A; Sawyer BM; Burnand KG
Br J Surg; 2002 Jun; 89(6):709-13. PubMed ID: 12027980
[TBL] [Abstract][Full Text] [Related]
18. Transplantation of autologous keratinocyte suspension in fibrin matrix to chronic venous leg ulcers: improved long-term healing after removal of the fibrin carrier.
Hartmann A; Quist J; Hamm H; Bröcker EB; Friedl P
Dermatol Surg; 2008 Jul; 34(7):922-9. PubMed ID: 18384617
[TBL] [Abstract][Full Text] [Related]
19. A gene signature of nonhealing venous ulcers: potential diagnostic markers.
Charles CA; Tomic-Canic M; Vincek V; Nassiri M; Stojadinovic O; Eaglstein WH; Kirsner RS
J Am Acad Dermatol; 2008 Nov; 59(5):758-71. PubMed ID: 18718692
[TBL] [Abstract][Full Text] [Related]
20. Basal cell carcinoma is not granulation tissue in the venous leg ulcer.
Jankovic A; Binic I; Ljubenovic M
Int J Low Extrem Wounds; 2008 Sep; 7(3):182-4. PubMed ID: 18757394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
